Home > Drug Search >
  • company_query: Alseres
  •   > 
Drug Filter
Category:
chemistry (13) biology (16)
Status:
Approved (1) Phase Ⅲ (4) Phase Ⅱ (12) Phase Ⅰ (12)
Clinical Stage:
Pending (8) Active (16) Discontinued (4)
Bio-Type:
Gene therapy (5) Immunocytokine (1) Cell therapy (1) Vaccine (5) Microbial extract (1) Other recombinant protein (1) Whole antibody (1)
Indication:
Breast cancer (2) Community-acquired pneumonia (CAP) (1) Metachromatic leukodystrophy (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Bronchitis (1) Epilepsy/Seizures (2) HCV infection (1) Hyperlipidemia (1) Insomnia (1) Non small cell lung cancer (NSCLC) (1) Non-alcoholic fatty liver disease (NAFLD) (2) Nephritis (2) Ovarian cancer (2) Parkinson's disease (PD) (1) Dupuytren's contracture (1) Peyronie's disease (1) Rheumatoid arthritis (RA) (1) Small cell lung cancer (SCLC) (1) Smoking cessation (1) Solid tumours (2) Colorectal cancer (2) Stroke (2) Methicillin-resistant staphylococcus aureus infections (1) Systemic inflammatory response syndrome (SIRS) (1) Hemophilia B (1) Septic shock (1) Mesothelioma (1) Celiac disease (1) Shock (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top